We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.63%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$59.8B
AUM Growth
+$5.07B
(+9.3%)
Cap. Flow
+$518M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
18.08%
Holding
2,992
New
38
Increased
2,358
Reduced
537
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$68M |
| 2 |
Truist Financial
TFC
|
+$55.9M |
| 3 |
ServiceNow
NOW
|
+$33.3M |
| 4 |
Uber
UBER
|
+$21.4M |
| 5 |
Las Vegas Sands
LVS
|
+$15.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$119M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$55.9M |
| 3 |
Apple
AAPL
|
+$48.3M |
| 4 |
iShares TIPS Bond ETF
TIP
|
+$22M |
| 5 |
VIAB
Viacom Inc. Class B
VIAB
|
+$16.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Financials | 15.53% |
| 3 | Healthcare | 13.38% |
| 4 | Consumer Discretionary | 10.07% |
| 5 | Industrials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Carnival Corporation Ltd
CCL
$38.1B
| $42.9M | 0.07% |
843,262
+21,597
| +3% | +$965K |
|
252
Cintas
CTAS
$81.9B
| $42.9M | 0.07% |
637,148
+20,484
| +3% | +$1.35M |
|
253
McCormick & Company Non-Voting
MKC
$13.7B
| $42.6M | 0.07% |
502,162
+1,734
| +0.3% | +$143K |
|
|
PXD
254
DELISTED
Pioneer Natural Resource Co.
PXD
| $42.6M | 0.07% |
281,439
+8,137
| +3% | +$1.08M |
|
255
Corpay
CPAY
$25B
| $42.3M | 0.07% |
147,176
+4,467
| +3% | +$1.32M |
|
256
Ameriprise Financial
AMP
$48.3B
| $42.3M | 0.07% |
253,938
-960
| -0.4% | -$149K |
|
257
Microchip Technology
MCHP
$40.3B
| $42.1M | 0.07% |
803,974
+43,976
| +6% | +$2.12M |
|
|
ANSS
258
DELISTED
Ansys
ANSS
| $41.8M | 0.07% |
162,490
+5,605
| +4% | +$1.33M |
|
259
Willis Towers Watson
WTW
$31.2B
| $41.5M | 0.07% |
205,655
+7,442
| +4% | +$1.43M |
|
260
Ametek
AME
$55.4B
| $41.4M | 0.07% |
415,231
+3,686
| +0.9% | +$349K |
|
|
261
Las Vegas Sands
LVS
$31.7B
| $41.3M | 0.07% |
598,742
+251,151
| +72% | +$15.7M |
|
|
PARA
262
DELISTED
Paramount Global Class B
PARA
| $41.3M | 0.07% |
982,880
+360,727
| +58% | +$14M |
|
263
Waters Corp
WAT
$37B
| $41.2M | 0.07% |
176,188
+7,942
| +5% | +$1.75M |
|
264
Omnicom Group
OMC
$21.6B
| $41M | 0.07% |
506,197
-23,191
| -4% | -$1.82M |
|
265
Best Buy
BBY
$18.2B
| $40.9M | 0.07% |
465,632
+11,113
| +2% | +$850K |
|
266
MSCI
MSCI
$41.6B
| $40.7M | 0.07% |
157,751
-7,697
| -5% | -$1.88M |
|
267
Cadence Design Systems
CDNS
$93.6B
| $40.7M | 0.07% |
587,009
+25,301
| +5% | +$1.7M |
|
268
Agilent Technologies
A
$39.1B
| $40.6M | 0.07% |
476,357
+1,030
| +0.2% | +$81.1K |
|
269
Ball Corp
BALL
$17.3B
| $40.3M | 0.07% |
622,809
+18,254
| +3% | +$1.24M |
|
270
VeriSign
VRSN
$26.2B
| $40.2M | 0.07% |
208,469
+5,905
| +3% | +$1.11M |
|
271
Weyerhaeuser
WY
$18B
| $40.1M | 0.07% |
1,327,519
+105,462
| +9% | +$3.06M |
|
272
CBRE Group
CBRE
$42.5B
| $39.8M | 0.07% |
648,850
+20,359
| +3% | +$1.13M |
|
273
Clorox
CLX
$11.6B
| $39.7M | 0.07% |
258,595
+4,193
| +2% | +$627K |
|
|
FITB
274
Fifth Third Bancorp
FITB
$51.2B
| $39.6M | 0.07% |
1,288,586
+40,364
| +3% | +$1.18M |
|
275
Republic Services
RSG
$64.8B
| $39.5M | 0.07% |
440,547
+17,294
| +4% | +$1.51M |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2019 Portfolio in Review
As of Q4 2019, RhumbLine Advisers held 2,992 positions worth $59.8B, up 9.3% from $54.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 2.7%. RhumbLine Advisers opened 38 new positions and exited 43, leaving the 2,992-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2019 buy was Envista: 126,664 shares worth $3.75M.
- RhumbLine Advisers added most to Bristol-Myers Squibb in Q4 2019, an estimated $68M increase.
- RhumbLine Advisers's biggest Q4 2019 reduction was Apple, cutting an estimated $48.3M.
- RhumbLine Advisers fully exited Celgene Corp in Q4 2019, selling an estimated $119M.
- RhumbLine Advisers's ten largest holdings make up 18% of its $59.8B portfolio in Q4 2019.
- RhumbLine Advisers opened 38 new positions and closed 43 in Q4 2019.
- RhumbLine Advisers's portfolio value rose 9.3% quarter-over-quarter to $59.8B.
Based on RhumbLine Advisers's 13F filing for Q4 2019, filed 5 Feb 2020.